论文信息 - Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). - 字舞流文

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3).

I. Hwang | S. Sym | S. Oh | W. Bae | J. Jang | Hyun Woo Lee | S. Go | J. Ji | J. H. Kim | J. Kang | Sang-Cheol Lee | D. Zang | Sanggon Park | Yaewon Yang | S. Jeon